The Ibrutinib (ILUDX) produced by Laos Big Bear Pharmaceuticals is a high-quality oral BTK inhibitor generic drug. While retaining the same core ingredients and mechanism of action as the original branded drug, it significantly reduces the price per box. Designed specifically for the treatment of chronic lymphocytic leukemia and mantle cell lymphoma, it offers patients a more cost-effective treatment option.
How much does Laos Big Bear version Ibrutinib cost?
The Laos Big Bear version of Ibrutinib is available in a specification of 140mg*90 capsules/box, priced at approximately $114. The actual price may be affected by various factors and should be based on the actual selling price.
Serious side effects and risks of Ibrutinib
Ibrutinib may cause serious side effects, some of which can be life-threatening, thus requiring high vigilance and prompt medical attention. First, bleeding problems are relatively common during treatment, but can also develop into severe or fatal bleeding. If you are also taking blood thinners (such as warfarin, apixaban, etc.), your risk of bleeding will further increase. Inform your medical provider immediately if you experience any of the following signs of bleeding: blood in your stool or black, tarry stools; bruising that is more severe than usual or large areas of bruising appearing for no reason; pink or brown urine; dizziness, weakness, or confusion; vomiting blood or vomit that looks like coffee grounds; coughing up blood or blood clots; changes in speech or a persistent, severe headache. Second, infection is another serious risk to be aware of. Bacterial, viral, or fungal infections can occur during treatment and can be fatal. Seek immediate medical attention if you develop fever, chills, weakness, confusion, or other symptoms of infection. Third, decreased blood cell counts (including white blood cells, platelets, and red blood cells) are common, but when severe, can increase the risk of infection, bleeding, or anemia. Your doctor should perform monthly blood tests. Fourth, heart rhythm problems (such as atrial fibrillation, atrial flutter) can occur in the treated population, especially in patients at high risk for heart disease, those with a prior history of arrhythmias, or those with concurrent infections. Symptoms include fast and irregular heartbeat, dizziness, shortness of breath, chest tightness, or even fainting. Fifth, high blood pressure may occur as a new condition or worsen existing hypertension. Your doctor may use blood pressure medication or adjust current medications to manage your blood pressure. Sixth, second primary cancers (including skin cancer or cancers of other organs) may occur during treatment. Regular skin examinations and cancer screenings are recommended. Seventh, tumor lysis syndrome (TLS) is another potential serious complication. Your doctor will monitor for this with blood tests. Although these side effects are serious, most can be effectively managed with early recognition and timely intervention.
Common side effects, storage, and general information for Ibrutinib
The common side effects of Ibrutinib vary slightly depending on the indication. In adult patients with mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenström's macroglobulinemia, and marginal zone lymphoma, the most common side effects include: diarrhea, muscle and bone pain, rash, nausea, bruising, tiredness, and fever. In adult patients with chronic graft-versus-host disease, the most common side effects include: tiredness, bruising, diarrhea, muscle cramps, mouth sores (stomatitis), nausea, and pneumonia. Notably, diarrhea is a very common side effect across indications. During treatment, drink plenty of fluids (such as water, clear broth, oral rehydration solutions, etc.) to help prevent dehydration, electrolyte imbalances, and kidney damage caused by fluid loss from diarrhea. If your diarrhea persists (for example, beyond 24-48 hours) or is accompanied by severe abdominal pain, fever, bloody stools, etc., be sure to inform your medical provider. Regarding storage, store Ibrutinib at room temperature between 20°C and 25°C, away from high heat or humidity. Always keep it in the original container, tightly closed and sealed to protect the medicine from light and moisture. Keep all medicines (including Ibrutinib and other drugs) out of the reach of children to prevent accidental ingestion. General information for the safe and effective use of Ibrutinib: Do not use this medicine for unapproved indications. Do not give your medicine to others with similar symptoms, as each person's condition and physical condition is different, and doing so may cause serious harm to their health. If you need more detailed information, ask your pharmacist or doctor for a product label written for health professionals. The active ingredient in Ibrutinib is ibrutinib. The inactive ingredients include croscarmellose sodium, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate; the capsule shell contains gelatin, titanium dioxide, and black ink.
